Search - tctmd.com

Displaying 21 - 40 of 616

Sort: Relevancy | Date

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Daily News

Repeat Rejection Still a Problem After Pediatric Heart Transplant

Todd Neale

October 23, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

Caitlin E. Cox

May 08, 2024

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Todd Neale

March 29, 2024

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

Todd Neale

March 08, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

Advertisement

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Repeat Rejection Still a Problem After Pediatric Heart Transplant

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Atherosclerosis Progression May Share Traits With Tumor Growth

INOCA May Be at the Root of Angina for Many Long-COVID Patients

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

FDA Grants MACE Reduction Indication for Semaglutide

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

March 2024 Dispatch for the CV Team

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content